Prevention of contrast-induced nephropathy in high-risk patients with hemofiltration.
Steven G
SG
Coca
Mark A
MA
Perazella
D000111:Acetylcysteine / Q000627:therapeutic use; D015986:Confounding Factors, Epidemiologic; D003287:Contrast Media / Q000009:adverse effects* / Q000627:therapeutic use; D006440:Hemofiltration; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D012107:Research Design; D014283:Triiodobenzoic Acids / Q000627:therapeutic use; D014556:Urine
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C044834:iodixanol; D000111:Acetylcysteine